Prestige (PBH) Director John F. Kelly Receives Award of 2,981 RSUs

What Happened
John F. Kelly, a director of Prestige Consumer Healthcare, received a grant of 2,981 restricted stock units (RSUs) on August 4, 2026. The Form 4 reports an acquisition (code A) of 2,981 shares at $0.00; the grant value is approximately $155,000 based on the issuer’s $52.00 closing share price on the grant date. The RSUs vest on the first anniversary of the grant and will be settled one-for-one into common shares upon vesting or earlier upon death, separation, or a change in control.

Key Details

• Transaction date: 2026-08-04; filing date: 2026-08-05 (timely).
• Transaction code: A (award/grant); reported price: $0.00.
• RSUs granted: 2,981; implied grant value: ~$155,000 (using $52.00 closing price).
• Vesting/settlement: Vests on first anniversary; settled by delivery of one share per RSU upon vesting or earlier upon death, separation, or change in control.
• Shares owned after transaction: not specified in the filing.
• Footnote: Award granted under the issuer’s director compensation program.

Context
This is a routine equity-based director compensation award, not an open-market purchase or sale. RSU grants compensate directors and do not necessarily indicate a personal buy/sell view of the stock; value is tied to the company’s share price at settlement.